SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cheng-Long Xie, Xiao-Dan Wang, Jie Chen, Hua-Zhen Lin, Yi-He Chen, Jia-Lin Pan, Wen-Wen Wang, A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson’s disease patients, Neurological Sciences, 2015, 36, 6, 833

    CrossRef

  2. 2
    Emily Bomasang-Layno, Iris Fadlon, Andrea N. Murray, Seth Himelhoch, Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis, Parkinsonism & Related Disorders, 2015, 21, 8, 833

    CrossRef

  3. 3
    Mei Ling Song, Mark A. Oldham, Kyung Min Park, Eun-Sook Lee, Hochang B. Lee, Yong Won Cho, Comparison of impact of insomnia on depression and quality of life in restless legs syndrome/Willis–Ekbom disease and primary insomnia patients, Sleep Medicine, 2015, 16, 11, 1403

    CrossRef

  4. 4
    Philippe Huot, Susan H. Fox, Jonathan M. Brotchie, Monoamine Reuptake Inhibitors in Parkinson’s Disease, Parkinson's Disease, 2015, 2015, 1

    CrossRef

  5. 5
    Maritza Sandoval-Rincón, Michel Sáenz-Farret, Adán Miguel-Puga, Federico Micheli, Oscar Arias-Carrión, Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease, Frontiers in Neurology, 2015, 6,

    CrossRef

  6. 6
    Paul J. Fitzgerald, Is elevated norepinephrine an etiological factor in some cases of Parkinson’s disease?, Medical Hypotheses, 2014, 82, 4, 462

    CrossRef

  7. 7
    Marco Mula, The interictal dysphoric disorder of epilepsy: Evidence in favor, Epileptology, 2014,

    CrossRef

  8. 8
    Miguel M Carvalho, Filipa L Campos, Bárbara Coimbra, José M Pêgo, Carla Rodrigues, Rui Lima, Ana J Rodrigues, Nuno Sousa, António J Salgado, Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits, Molecular Neurodegeneration, 2013, 8, 1, 14

    CrossRef

  9. 9
    Laura Marsh, Depression and Parkinson’s Disease: Current Knowledge, Current Neurology and Neuroscience Reports, 2013, 13, 12

    CrossRef

  10. 10
    Megan Konerth, Jennifer Childers, Exercise: A possible adjunct therapy to alleviate early Parkinson disease, Journal of the American Academy of Physician Assistants, 2013, 26, 4, 30

    CrossRef

  11. 11
    ROSA QUELHAS, Psychiatric Care in Parkinson’s Disease, Journal of Psychiatric Practice, 2013, 19, 2, 118

    CrossRef

  12. 12
    Marco Mula, The Interictal Dysphoric Disorder of Epilepsy: a Still Open Debate, Current Neurology and Neuroscience Reports, 2013, 13, 6

    CrossRef

  13. 13
    David Myland Kaufman, Mark J. Milstein, Kaufman's Clinical Neurology for Psychiatrists, 2013,

    CrossRef

  14. 14
    Ryan J. Uitti, Treatment of Parkinson's disease: focus on quality of life issues, Parkinsonism & Related Disorders, 2012, 18, S34

    CrossRef

  15. 15
    Katrina L. Paumier, Andrew D. Siderowf, Peggy Auinger, David Oakes, Lalitha Madhavan, Alberto J. Espay, Fredy J. Revilla, Timothy J. Collier, Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease, Movement Disorders, 2012, 27, 7
  16. 16
    Dag Aarsland, Uwe Ehrt, Irena Rektorova, Cognitive and psychiatric disturbances in Parkinson’s disease, Aging Health, 2011, 7, 1, 123

    CrossRef

  17. 17
    Dag Aarsland, Sven Påhlhagen, Clive G. Ballard, Uwe Ehrt, Per Svenningsson, Depression in Parkinson disease—epidemiology, mechanisms and management, Nature Reviews Neurology, 2011, 8, 1, 35

    CrossRef

  18. 18
    Roseanne DeFronzo Dobkin, Matthew Menza, Karina L. Bienfait, Michael Gara, Humberto Marin, Margery H. Mark, Allison Dicke, Jill Friedman, Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management, The American Journal of Geriatric Psychiatry, 2011, 19, 3, 222

    CrossRef

  19. 19
    Mark J. Rapoport, Do Antidepressants Improve Recovery From Neurologic Illness?, The American Journal of Geriatric Psychiatry, 2011, 19, 12, 985

    CrossRef

  20. 20
    Karen L. Eskow Jaunarajs, Mariana Angoa-Perez, Donald M. Kuhn, Christopher Bishop, Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatment, Neuroscience & Biobehavioral Reviews, 2011, 35, 3, 556

    CrossRef

  21. 21
    Tzu-Ting Huang, Hua-Yun Hsu, Bi-Hwa Wang, Kang-Hua Chen, Quality of life in Parkinson’s disease patients: validation of the Short-Form Eight-item Parkinson’s Disease Questionnaire (PDQ-8) in Taiwan, Quality of Life Research, 2011, 20, 4, 499

    CrossRef

  22. 22
    Elisabeth Andreadou, Maria Anagnostouli, Vassilis Vasdekis, Evangelia Kararizou, Michael Rentzos, Theodoros Kontaxis, Ioannis Evdokimidis, The impact of comorbidity and other clinical and sociodemographic factors on health-related quality of life in Greek patients with Parkinson's disease, Aging & Mental Health, 2011, 15, 7, 913

    CrossRef

  23. 23
    Albert F.G. Leentjens, The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinsonʼs Disease, Drugs, 2011, 71, 3, 273

    CrossRef

  24. 24
    Chih-Chuan Pan, Chen-Fu Shaw, Jong-Khing Huang, Chun-Chi Kuo, Daih-Huang Kuo, Pochuen Shieh, Ti Lu, Wei-Chuan Chen, Chin-Man Ho, Chung-Ren Jan, Effect of nortriptyline on cytosolic Ca2+ regulation and viability in PC3 human prostate cancer cells, Drug Development Research, 2010, 71, 5
  25. 25
    Alberto Raggi, Matilde Leonardi, Daniela Ajovalasit, Francesco Carella, Paola Soliveri, Alberto Albanese, Luigi Romito, Functioning and disability in Parkinson's disease, Disability and Rehabilitation, 2010, 32, sup1, S33

    CrossRef

  26. 26
    Paolo Barone, Werner Poewe, Stefan Albrecht, Catherine Debieuvre, Dan Massey, Olivier Rascol, Eduardo Tolosa, Daniel Weintraub, Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial, The Lancet Neurology, 2010, 9, 6, 573

    CrossRef

  27. 27
    Carole A. Joint, Claire Fletcher, David Foxcroft, Tipu Z. Aziz, The Relationship Between Self-Perception of Ability and Actual Ability in Parkinsonian Patients Performing Motor Tasks, Journal of Neuroscience Nursing, 2010, 42, 2, E1

    CrossRef

  28. 28
    Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Margery H. Mark, Michael Gara, Karina Bienfait, Allison Dicke, Alex Kusnekov, The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease, Psychosomatics, 2010, 51, 6, 474

    CrossRef

  29. 29
    Oliver Tüscher, Ludger Tebartz van Elst, Depression and Movement Disorders,
  30. 30
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,